Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Cost of diabetes care in US rises to $412.9 billion in 2022
The total annual cost of caring for Americans with diabetes in 2022 was an estimated $412.9 billion, and one in four total health care dollars in the U.S. went toward diabetes care, according to a report.
Severe anion gap metabolic acidosis in a patient with type 2 diabetes
A man aged 51 years with a history of alcohol use disorder and type 2 diabetes treated with metformin and glimepiride and alcohol presented to the hospital for a witnessed cardiac arrest at home.
Log in or Sign up for Free to view tailored content for your specialty!
DNA methylation markers may help predict diabetic kidney disease progression
Using DNA methylation markers in blood samples may help predict the progression of diabetic kidney disease in patients with type 2 diabetes, recent data suggests.
Meta-analysis confirms benefits of SGLT2 inhibitors in various high-risk populations
SGLT2 inhibitors reduce risk for CV death and HF events in patients with any or multiple of HF, type 2 diabetes and chronic kidney disease, according to a meta-analysis published in the Journal of the American College of Cardiology.
VIDEO: ‘We have amazing tools today’ to reduce cardiometabolic complications
PHILADELPHIA — In this Healio video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, co-chair of the Heart in Diabetes CME Conference, discusses the accomplishments of the meeting.
Finerenone may improve kidney disease-related CV complications in type 2 diabetes
Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, may improve CV risk among patients with type 2 diabetes and kidney disease and those with albuminuria, according to a FIDELITY substudy published in JAMA Cardiology.
VIDEO: In COVID-19, MI risk elevated with at least one cardiometabolic risk factor
PHILADELPHIA — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Susan Cheng, MD, MPH, MMSc, discusses the excess risk for heart attack in patients with COVID-19.
PAD plus diabetes ‘unique’ malignant phenotype; proper medical therapy essential
PHILADELPHIA — Peripheral artery disease is often the first manifestation of CVD in patients with type 2 diabetes, and represents a “unique” malignant phenotype, a speaker said during the Heart in Diabetes CME Conference.
Imperfect prediabetes diagnosis provides opportunity to identify, prevent diabetes
PHILADELPHIA — Prediabetes is a high-risk state associated with substantial morbidity and mortality, yet consensus is needed regarding an “optimal” definition to better identify who could benefit from interventions, according to a speaker.
VIDEO: Heart in Diabetes convened ‘the very top faculty ... globally’
PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, co-chair of the Heart in Diabetes CME Conference, discusses the mission and purpose of the meeting.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read